Speaker: Carol A. Burke, MD, FACG

Learning Objective: Discuss the recent guideline recommendations regarding the approach to detection of Lynch Syndrome in those with colorectal neoplasia.

Source: 2016 ACG Postgraduate Course, Las Vegas, NV

Explore the premier gastroenterology education site, the ACG Education Universe at http://universe.gi.org, for CME and thousands of other presentations by world experts in gastroenterology and hepatology.

Learn about our dedicated Lynch Syndrome Center - https://www.dana-farber.org/lynchsyndrome Sapna Syngal, MD, MPH, Director of Research at Dana-Farber's Center for Cancer Genetics and Prevention, delivers opening remarks for the inaugural DFCI Lynch Syndrome Conference, with an overview of Lynch syndrome, from discovery to current research and treatment, and Dana-Farber’s special place in that history.

Visit: https://www.dana-farber.org/LynchSyndrome Matthew Yurgelun, MD, a gastrointestinal medical oncologist and Director of the Lynch Syndrome Center at Dana-Farber Cancer Institute describes how the Center provides coordination of care and individual care plans for Lynch syndrome patients through a team of dedicated physicians, nurse practitioners, genetic counselors and other Lynch syndrome specialists.

In this episode of "One in Two: A Manchester Cancer Research Podcast", we speak to Professor Emma Crosbie about her research in womb cancer and the breakthrough she made in discovering a link between Lynch syndrome and womb cancer.

We discuss the steps Emma and her team took to change NICE guidance on testing for Lynch syndrome for women with womb cancer, and what this now means for the many women and their families with this disease.

Show notes:

Emma Crosbie’s research profile: https://www.research.mancheste....r.ac.uk/portal/emma.

Cancer futures: https://www.bmh.manchester.ac.uk/stories/cancer/

Peaches trust: https://peachestrust.org/
What is cervical screening? https://www.nhs.uk/conditions/cervical-screening/

Macmillan Cancer support: https://www.macmillan.org.uk/

Read more in this blog from the Policy@Manchester Team and hear directly from people who will be affected by this change in healthcare policy: https://www.policy.manchester.....ac.uk/activities/lyn


Speaker profile:

Professor Emma Crosbie

Emma Crosbie is Professor of Gynaecological Oncology at The University of Manchester and Manchester University NHS Foundation Trust. She is also the lead for the cancer prevention and early detection research theme at the NIHR Manchester Biomedical Research Centre. Her research interests include screening, prevention and the early detection of gynaecological cancers, as well as developing new treatments and interventions for women with established disease.